Observational Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 6, 2022; 10(31): 11403-11410
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11403
Table 1 Detailed data of Mendelian randomization
Variable
Consortium
PMID
Population
Sex
Sleep apneaUKB-EuropeanMales and females
LDL-CGLGC24097068EuropeanMales and females
HDL-CGLGC24097068EuropeanMales and females
TGGLGC24097068EuropeanMales and females
TCGLGC24097068EuropeanMales and females
Table 2 Results from two sample Mendelian randomization analysis
Lipid
Method
Number of SNPs
P value
OR
95%CI
LDL and Sleep apneaMR Egger420.580.990.99-1.00
Weighted median420.970.990.99-1.00
Inverse variance weighted420.851.000.99-1.00
Simple mode420.311.000.99-1.00
Weighted mode420.740.990.99-1.00
HDL and sleep apneaMR Egger550.910.990.99-1.00
Weighted median550.351.000.99-1.00
Inverse variance weighted550.291.000.99-1.00
Simple mode550.221.000.99-1.00
Weighted mode550.331.000.99-1.00
TG and Sleep apneaMR Egger350.921.000.99-1.00
Weighted median350.820.990.99-1.00
Inverse variance weighted350.571.000.99-1.00
Simple mode350.590.990.99-1.00
Weighted mode350.941.000.99-1.00
TC and Sleep apneaMR Egger510.330.990.99-1.00
Weighted median510.680.990.99-1.00
Inverse variance weighted510.821.000.99-1.00
Simple mode510.201.000.99-1.00
Weighted mode510.701.000.99-1.00
Table 3 Heterogeneity test and level pleiotropy test
Lipid
Heterogeneity test, inverse variance weighted
Level pleiotropy test

Q
df
P value
P value
LDL33.04410.8070.459
HDL67.98540.0960.408
TG34.87340.4270.823
TC48.34500.5400.247